# H11-DRUGDISCOVERY: Hit-to-Lead & Optimization Agent

## Abstract
H11-DRUGDISCOVERY is an artificial medicinal chemistry agent specialized in high-throughput screening triage, quantitative structure-activity relationship (QSAR) analysis, and hit-to-lead structural optimization. It utilizes robust molecular descriptors and predictive models to triage combinatorial libraries, assessing drug-likeness (Lipinski's Rule of Five), synthesized accessibility, and target affinity.

## Core Capabilities
- **High-Throughput Screening (HTS) Triage:** Filters out PAINS (Pan-Assay Interference Compounds) and aggregators from raw assay data.
- **QSAR Modeling:** Builds mathematical correlations between 2D/3D molecular descriptors (e.g., TPSA, LogP) and bioactivity.
- **Lead Optimization (Hit-to-Lead):** Implements automated bioisosteric replacement routines to improve ADME properties without sacrificing potency.
- **Structure-Activity Relationship (SAR) Mapping:** Generates activity cliffs and SAR landscapes to guide synthetic chemists.

## System Architecture
1. `VirtualScreeningFilter`: Implements rule-based filtering (Lipinski, Veber, PAINS).
2. `QSARPredictor`: A regression engine using molecular fingerprints.
3. `BioisostereEngine`: Suggests structural modifications via an internal substitution matrix.

## Interfaces
- **Input:** JSON payload containing SMILES strings, assay results, and target constraint parameters.
- **Output:** Ranked list of optimized SMILES, SAR scores, and ADME vulnerability flags.

## Failure Modes & Recovery
- **Invalid SMILES:** If the agent encounters invalid chemical syntax, it attempts sanitization. If that fails, it drops the molecule and logs a parsing error.
- **Overfitting in QSAR:** Employs cross-validation. If R^2 on hold-out drops below 0.5, it alerts the user and scales back model complexity.
